GPR156: A Drug Target / Disease Biomarker (G165829)

GPR156: A Drug Target / Disease Biomarker

GPR156 is a G protein-coupled receptor (GPCR) that is expressed in various tissues and cells throughout the body. It is involved in several physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPR156 has also been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

GPR156 is a member of the GPCR family, which includes over 300 different proteins that are involved in a wide range of physiological processes. GPCR signaling pathways involve the interaction between GPCRs and their ligands, which are either natural substances in the body or synthetic molecules that can activate the receptor. When a GPCR is activated, it sends a signal to the cell through a complex process that involves the interaction of several different proteins. This process is regulated by the G protein, which is a transmembrane protein that can interact with the GPCR and regulate the flow of signaling molecules into the cell.

GPR156 is a GPCR that is expressed in various tissues and cells throughout the body, including the brain, spinal cord, and peripheral tissues. It is involved in several physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPR156 is also involved in the regulation of pain perception and the modulation of anxiety and depression-like behaviors.

One of the unique features of GPR156 is its potential as a drug target. GPR156 has been shown to be involved in the regulation of a wide range of physiological processes, including pain perception, neurotransmission, and hormone signaling. This makes it an attractive target for the development of new drugs that can treat a variety of conditions. GPR156 is also a good candidate as a biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

GPR156 is involved in the regulation of pain perception, which is a complex physiological process that involves the interaction between the brain and the endocrine system. GPR156 is shown to be involved in the regulation of pain perception by sending signals to the endocrine system to regulate the production of pain-related hormones. GPR156 is also involved in the regulation of neurotransmission, which is the process by which signals are transmitted from the brain to other parts of the body. GPR156 is shown to be involved in the regulation of neurotransmission by interacting with a variety of neurotransmitter receptors.

GPR156 is also involved in the regulation of hormone signaling, which is the process by which hormones are produced and regulated by the endocrine system. GPR156 is shown to be involved in the regulation of hormone signaling by interacting with hormone-producing cells and hormone receptors. This is important because GPR156 has been shown to be involved in the regulation of hormone signaling in a variety of tissues and cells.

In addition to its involvement in pain perception, neurotransmission, and hormone signaling, GPR156 is also involved in the regulation of other physiological processes. For example, GPR156 is involved in the regulation of anxiety and depression-like behaviors, which are important indicators of the functioning of the nervous system. GPR156 is also involved in the regulation of sleep-wake cycles, which are important for maintaining the balance of hormones in the body and regulating many physiological processes.

GPR156 is also involved in the regulation of sensory perception, which is the process by which the brain interprets the incoming information from the senses. GPR156 is shown to be involved in the regulation of sensory perception by interacting with the sensory neurons that transmit information from the senses

Protein Name: G Protein-coupled Receptor 156

Functions: Orphan receptor

The "GPR156 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR156 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme